- Conditions
- Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), +91 more
- Locations
-
- Chedoke-McMaster Hospitals Hamilton, Ontario, Canada
- Juravinski Cancer Centre at Hamilton Health Sciences Hamilton, Ontario, Canada
- Princess Margaret Hospital Phase 2 Consortium Toronto, Ontario, Canada
- University Health Network-Princess Margaret Hospital Toronto, Ontario, Canada
Clinical trial condition
Splenic Marginal Zone Lymphoma
Explore clinical trials studying Splenic Marginal Zone Lymphoma. Study availability and eligibility vary by location and protocol.
99 public trials
3 recruiting studies
Splenic Marginal Zone Lymphoma trial results
NCT00621452
- Conditions
- B-cell Chronic Lymphocytic Leukemia, Blood Protein Disorders, Cardiovascular Diseases, +38 more
- Locations
-
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
NCT00110071
- Conditions
- Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +46 more
- Locations
-
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
Completed
Oblimersen Sodium and Rituximab in Treating Patients With Recurrent B-cell Non-Hodgkin Lymphoma
NCT00054639
- Conditions
- Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +60 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT00290472
- Conditions
- B-cell Chronic Lymphocytic Leukemia, Blood Protein Disorders, Burkitt Lymphoma, +54 more
- Locations
-
- University of Chicago Chicago, Illinois, United States
- Decatur Memorial Hospital Decatur, Illinois, United States
- Evanston Hospital CCOP Evanston, Illinois, United States
- Ingalls Memorial Hospital Harvey, Illinois, United States
NCT01231919
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Acute Leukemias of Ambiguous Lineage, Acute Myeloid Leukemia/Transient Myeloproliferative Disorder, +130 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- Childrens Hospital of Orange County Orange, California, United States
- University of California San Francisco Medical Center-Parnassus San Francisco, California, United States
- Children's National Medical Center Washington D.C., District of Columbia, United States
NCT01233921
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +151 more
- Locations
-
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
NCT00499811
- Conditions
- Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, +112 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
- University of Southern California Los Angeles, California, United States
- Emory University/Winship Cancer Institute Atlanta, Georgia, United States
- National Institutes of Health Bethesda, Maryland, United States
NCT00458731
- Conditions
- Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, +116 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT00769288
- Conditions
- Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, +107 more
- Locations
-
- Wayne State University Detroit, Michigan, United States